GoldenGolden
Advanced Search
Agile Therapeutics

Agile Therapeutics

Agile Therapeutics is a biotechnology and pharmaceutical company headquartered in Princeton, New Jersey developing contraceptive and healthcare products for women.

Agile Therapeutics is a biotechnology and pharmaceutical company that is headquartered in Princeton, New Jersey. The company is developing contraceptives and other healthcare products for women.

Products
Twirla

Their primary contraceptive drug candidate is called Twirla, or AG200-15, and is administered through a contraceptive skin path. Twirla contains a combination of hormonal contraceptives such as ethinyl estradiol, and levonorgestrel, and delivers them through a skin patch over the course of a seven day period. The skin patch is administered for 3 straight weeks followed by a one week break without the skin patch.

Funding
Series A

On May 5, 2010 Agile Therapeutics completed their series A funding round with $1 million in funding from undisclosed investors.

Series B

On June 14, 2010 Agile Therapeutics completed their series B funding round with $45 million in funding from Investor Growth Capital Limited (lead investor), Care Capital (lead investor), ProQuest Investments, Novitas Capital, and Kaiser Permanente Ventures.

Series C

On July 19, 2012 Agile Therapeutics completed their series C funding round with $40 million in funding from Aisling Capital (lead investor), Care Capital, Investor Growth Capital, ProQuest Investments, Kaiser Permanente Ventures, and Novitas Capital.

Private placement

On March 4, 2019 Agile Therapeutics announced a definitive stock purchase agreement with Perceptive Advisors that resulted in $7.8 million of gross proceeds for Agile Therapeutics. Perceptive Advisors were given approximately 8.4 million privately placed shares of common stock in Agile Therapeutics at $0.93 per share.

Timeline

July 19, 2012
Agile Therapeutics raises a $40,000,000 series C round from Kaiser Permanente Ventures, Novitas Capital and Patricia Industries.
June 14, 2010
Agile Therapeutics raises a $45,000,000 series B round.
January 12, 2010
Agile Therapeutics raises a $1,010,822 series A round.
1997
Agile Therapeutics was founded.

Funding rounds

People

Further reading

Documentaries, videos and podcasts

Companies

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.